drugset / Trial / NCT01227681
Study of the Neuro-protective Effect of Granulocyte-colony Stimulating Factor on Early Stage Parkinson's Disease
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to evaluate the effectiveness of neuroprotection from granulocyte colony-stimulating factor on Parkinson disease
Timeline
- Start
- 2010-06
- Primary completion
- 2013-12
- Completion
- 2013-12
Outcome
Outcome not reported
Stopped (Enrollment): “Difficulty in Recruitment”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | G-CSF | Unknown | 1.65 ug/kg | Subcutaneous |
| Subject | G-CSF | Unknown | 3.3 ug/kg | Subcutaneous |